Pradaxa (Boehringer Ingelheim Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Pradaxa drug offered from Boehringer Ingelheim Pharmaceuticals Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | dabigatran etexilate mesylate |
| SUBSTANCE NAME: | DABIGATRAN ETEXILATE MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-11-23 |
| END MARKETING DATE: | 0000-00-00 |
Pradaxa HUMAN PRESCRIPTION DRUG Details:
| Item Description | Pradaxa from Boehringer Ingelheim Pharmaceuticals Inc. |
| LABELER NAME: | Boehringer Ingelheim Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 110(mg/1) |
| START MARKETING DATE: | 2015-11-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0597-0108_cc1eb28e-8ad7-ba33-594a-8ca2cc1768f0 |
| PRODUCT NDC: | 0597-0108 |
| APPLICATION NUMBER: | NDA022512 |
Other DABIGATRAN ETEXILATE MESYLATE Pharmaceutical Manufacturers / Labelers:
